The Frankel Innovation Initiative is a $20 million fund supporting the research and development of life-saving therapies at Michigan Medicine. The fund targets projects led by U-M faculty that have the potential for rapid clinical application and groundbreaking impact. FFMI is administering the fund.
The Frankel Innovation Initiative encourages faculty to collaborate with experts at U-M and outside institutions in order to help quickly move early-stage research to results that positively affect human health and save lives.
The $20 million gift will be used to fund five to seven projects annually, with each project receiving between $250,000 – $1 million. Applications are due in April and funding begins in July. Funded projects will be selected by an oversight committee of internationally renowned scientists and venture capitalists external to U-M.
Proposals for the 2020 round of funding are due April 1, 2020.
Applications will be managed through Competition Space.
The initiative is designed to build on best practices of the standout programs developed at U-M and other top institutions, and capitalizes on U-M’s extensive biomedical research enterprise as the top public university in research spending in the United States.